N-Methyl-N-Cbz-D-alanine | CAS:68223-03-0

We serve N-Methyl-N-Cbz-D-alanine CAS:68223-03-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-Methyl-N-Cbz-D-alanine

CAS No: 68223-03-0
Product Name: N-Methyl-N-Cbz-D-alanine
Other Name:
N-Methyl-N-Cbz-D-alanine
N-[(Benzyloxy)carbonyl]-N-methyl-D-alanine
N-Methyl-N-Cbz-Ala
(2R)-2-[methyl(phenylmethoxycarbonyl)amino]propanoic acid
Z-N-Me-D-Ala-OH
 
Density: 1.2±0.1 g/cm3
Boiling Point: 389.5±31.0 °C at 760 mmHg
Molecular Formula: C12H15NO4
Molecular Weight: 237.252
Flash Point: 189.4±24.8 °C
Exact Mass: 237.100113
PSA: 66.84000
LogP: 2.20
Vapour Pressure: 0.0±0.9 mmHg at 25°C
Index of Refraction: 1.545
 
Specification
Appearance: White powder
Assay: ≥98.0%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like N-Methyl-N-Cbz-D-alanine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Z-N-Me-D-Ala-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R)-2-[methyl(phenylmethoxycarbonyl)amino]propanoic acid Use and application,N-[(Benzyloxy)carbonyl]-N-methyl-D-alanine technical grade,usp/ep/jp grade.


Related News: After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.ethyl 4-(1-methyl-5-nitrobenzimidazol-2-yl)butanoate manufacturer Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.4-(1-Methyl-5-nitro-1H-benzimidazol-2-yl)butanoic acid supplier An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.4-Dibenzothienylboronic acid vendor ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.In these situations, the API is not a single substance but the culmination of various ingredients.